Information Provided By: 
Fly News Breaks for April 24, 2015
BIIB, FWP
Apr 24, 2015 | 07:40 EDT
Leerink raised its price target for Forward Pharma (FWP) shares to $53 saying it left a meeting with management and a former patent judge positive on the company's strategy to monetize its dimethyl fumarate patents. Forward is strengthening its position to bring infringement suits in multiple countries against Biogen (BIIB), Leerink tells investors. The firm keeps an Outperform rating on Forward Pharma.
News For FWP;BIIB From the Last 2 Days
BIIB
Apr 24, 2024 | 08:50 EDT
Check out this morning's top movers from around Wall Street, compiled by The Fly. UP AFTER EARNINGS... To see the rest of the story go to thefly.com. See Story Here
BIIB
Apr 24, 2024 | 06:50 EDT
BIIB
Apr 24, 2024 | 06:48 EDT
